SCHEMBL6002629

SCHEMBL6002629

[O]C(=O)N(OC(F)(F)C(F)(F)C(F)(F)F)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.34
NR1H3 Q13133 4/20 0.34
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CES1 P23141 2/20 0.32
TACR1 P25103 2/20 0.32
NR1H2 P55055 2/20 0.31
MLYCD O95822 2/20 0.31
POLQ O75417 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ALDH1A1 P00352 2/20 0.30
NPC1 O15118 1/20 0.30
POLB P06746 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002564 0.83 ATM (0.33) NPSR1NR1H3ATMTDP1L3MBTL1
SCHEMBL6002568 0.71 TACR1 (0.30) TACR1
SCHEMBL6002270 0.70 NPSR1 (0.38) NPSR1NR1H3CES1TACR1NR1H2
SCHEMBL5170181 0.69 NPSR1 (0.40) NPSR1NR1H3ATMTDP1L3MBTL1
SCHEMBL4131826 0.69 NPSR1 (0.43) NPSR1ATMTDP1L3MBTL1KMT2A
SCHEMBL5932403 0.68 ALDH1A1 (0.46) NPSR1L3MBTL1KMT2AMEN1CYP3A4
SCHEMBL8084617 0.67 CES1 (0.39) NPSR1NR1H3ATMTDP1L3MBTL1
SCHEMBL6012131 0.67 NPSR1 (0.38) NPSR1NR1H3ATMTDP1L3MBTL1
SCHEMBL17681664 0.67 KMT2A (0.38) NPSR1NR1H3ATMTDP1L3MBTL1
Hydrochloric Acid SCHEMBL27617832 0.66 PDK1 (0.38) NPSR1NR1H3L3MBTL1TACR1NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed